SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 413.19+1.1%Jan 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jack of All Trades who wrote (155819)4/2/2020 8:50:14 PM
From: Secret_Agent_Man  Read Replies (1) of 219057
 
Here's the thing JoT, all the deaths not just nyc but nationwide are roughly 7K/day,

indexmundi.com

now what is known, is that there is NO SPECIFIC TEST for COVID-19 yet! but there are PCR tests for coronavirus.

now if you take one step forward, Influenza deaths worldwide are roughly 300K-500K/yr with severe cases 3-5Million/yr.

medscape.com

and fact most people have had coronavirus since there are literally 100's of varities of corona-before you get the 19, which btw, there is no specific test for, instead of testing for flu, these people are now being tested for corona which most of the general population has had at one time or another since they are the cause for common colds-

Also it is known that quinolones and macrolids both are active against viruses, specifically, quinolones like gemifloxin, moxifloxin et.al. interfere with the DNA topo-isomerase of viruses and macrolids-Zithromax-azithromycin kill the RNA transcriptase function of viruses so they cannot replicate-

but no one is discussing that at all-

there is a lot of Flummery going on here...

"Ribosome-targeting macrolide antibiotics were thought to simply plug the nascent peptide exit tunnel and interrupt the synthesis of any protein. However, structural, biochemical, and genome-wide studies have revealed that macrolides are highly selective modulators of protein synthesis.

Macrolide molecules together with specific nascent peptides in the ribosomal tunnel allosterically affect the functional properties of the catalytic center of the ribosome.

The macrolide-bound ribosome is unable to polymerize specific amino acid sequences in the nascent protein.

Programmed translation arrest that controls the expression of macrolide resistance genes exploits the context-specific action of macrolides."


sciencedirect.com

Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?

link.springer.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext